论文部分内容阅读
国内著名的医疗机构北京协和医院和全球十大药厂之一的惠氏公司2006年3月22日联合宣布,由双方合作建立的早期临床药物研究中心在北京正式成立。中国医学科学院、北京协和医科大学校长刘德培教授,北京协和医院党委书记鲁重美教授,常务副院长李学旺教授,惠氏公司董事长、首席执行官兼总裁艾斯纳先生等嘉宾出席了当天在北京协和医院举行的成立仪式。这是惠氏在中国成立的首个早期临床药物研发中心。双方希望通过加强协作,以加快各种创新性药物的开发速度。同时该中心将与惠氏在全球其他地方设立的同类早期临床药物研究中心相配合,提高开
The well-known medical institution Peking Union Medical College Hospital and Wyeth, one of the top ten pharmaceutical companies in the world, jointly announced on March 22, 2006 that the Early Clinical Drug Research Center established by the two parties was formally established in Beijing. Prof. Liu Depei, President of Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Prof. Lu Zhongmei, Party Secretary of Peking Union Medical College Hospital, Prof. Li Xuewang, Executive Vice President, Mr. Eisner, Chairman, CEO and President of Wyeth attended the day in Beijing Concord Hospital held its establishment ceremony. This is Wyeth’s first early clinical drug research and development center in China. Both sides hope to speed up the development of various innovative drugs by strengthening their collaboration. At the same time, the center will be compatible with similar early clinical drug research centers set up by Wyeth in other parts of the world